Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This bill caps out-of-pocket costs for inhalers and nebulizers used to treat asthma and chronic obstructive pulmonary disease (COPD) at $15 per 30-day supply across private insurance, Medicare, and Medicaid. The legislation applies to all types of inhalation medications and related equipment such as spacers and masks, requiring health insurance plans to waive deductibles for these products and count any cost-sharing toward patients' annual out-of-pocket maximums. The bill also establishes a government payment program for uninsured individuals who need inhalers, ensuring they pay no more than $15 per month's supply if providers register with the program. These provisions take effect January 1, 2026, and affect millions of Americans with respiratory conditions who currently struggle with high medication costs, as well as employers who offer health plans and insurance companies that must adjust their coverage requirements.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.